Global Travel Vaccine Market to 2032
Overview
The Global Travel Vaccine Market is expected to reach a 12.94 USD Billion by 2032 and is projected to grow at a CAGR of 9.76% from 2025 to 2032.
Revenue, 2024 (USD Billion)
6.60
Forecast, 2032 (USD Billion)
12.94
CAGR, 2024 - 2032
9.76%
Report Coverage
Global
Global Travel Vaccine Market 2018-2032 USD Billion
Global Travel Vaccine Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 6.60 USD Billion
- Projected Market Size (2032): 12.94 USD Billion
- CAGR (2025-2032): 9.76%
Key Findings of Global Travel Vaccine Market
- The Global Travel Vaccine Market was valued at 12.94 USD Billion in 2024.
- The Global Travel Vaccine Market is likely to grow at a CAGR of 9.76% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 5.42 USD Billion
- The fastest growing segment Typhoid in Disease Segment grew Fastest with a CAGR of 15.94% during the forecast period from 2024 to 2032.
Global Travel Vaccine Market Scope
Global Travel Vaccine Market Segmentation & Scope
Route of Administration
- Injectable
- Oral
Disease
- Others
- Polio
- COVID-19
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Gender
- Male
- Female
Distribution Channel
- B2C
- B2B
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Patient Type
- Geriatric
- Pediatric
- Adult
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Type
- Live-Attenuated Vaccines
- Inactivated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Toxoid Vaccines
- Viral Vector Vaccines
- DNA Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Global Travel Vaccine Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 6.60 USD Billion |
| Market Value in 2032 | 12.94 USD Billion |
| CAGR (2025-2032) | 9.76% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Route of Administration,Disease,Gender,Distribution Channel,Age Group,Patient Type,Category,Type,Composition |
Regional Insights:
-
Leading Market (2024-2032): Global, leading in terms of revenue 6.60 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 758.51 USD Million in 2024.
Segments and Scope
-
Global Travel Vaccine Market to 2032, By Route of Administration
- Injectable is the largest segment in Global Travel Vaccine Market to 2032 with a revenue of 5.42 USD Billion in the year 2024.
- Injectable is the Fastest growing segment in Global Travel Vaccine Market to 2032 with a Growth rate of 9.88 % in forecast period 2025-2032.
-
Global Travel Vaccine Market to 2032, By Disease
- Typhoid is the largest segment in Global Travel Vaccine Market to 2032 with a revenue of 1.20 USD Billion in the year 2024.
- Typhoid is the Fastest growing segment in Global Travel Vaccine Market to 2032 with a Growth rate of 15.94 % in forecast period 2025-2032.
-
Global Travel Vaccine Market to 2032, By Gender
- Male is the largest segment in Global Travel Vaccine Market to 2032 with a revenue of 3.53 USD Billion in the year 2024.
- Male is the Fastest growing segment in Global Travel Vaccine Market to 2032 with a Growth rate of 9.92 % in forecast period 2025-2032.
-
Global Travel Vaccine Market to 2032, By Distribution Channel
- B2B is the largest segment in Global Travel Vaccine Market to 2032 with a revenue of 5.14 USD Billion in the year 2024.
- B2B is the Fastest growing segment in Global Travel Vaccine Market to 2032 with a Growth rate of 9.89 % in forecast period 2025-2032.
-
Global Travel Vaccine Market to 2032, By Age Group
- 20-50 Years is the largest segment in Global Travel Vaccine Market to 2032 with a revenue of 3.35 USD Billion in the year 2024.
- 20-50 Years is the Fastest growing segment in Global Travel Vaccine Market to 2032 with a Growth rate of 10.12 % in forecast period 2025-2032.
-
Global Travel Vaccine Market to 2032, By Patient Type
- Adult is the largest segment in Global Travel Vaccine Market to 2032 with a revenue of 3.06 USD Billion in the year 2024.
- Adult is the Fastest growing segment in Global Travel Vaccine Market to 2032 with a Growth rate of 10.27 % in forecast period 2025-2032.
-
Global Travel Vaccine Market to 2032, By Category
- Recommended Vaccine is the largest segment in Global Travel Vaccine Market to 2032 with a revenue of 3.15 USD Billion in the year 2024.
- Recommended Vaccine is the Fastest growing segment in Global Travel Vaccine Market to 2032 with a Growth rate of 10.07 % in forecast period 2025-2032.
-
Global Travel Vaccine Market to 2032, By Type
- Inactivated Vaccines is the largest segment in Global Travel Vaccine Market to 2032 with a revenue of 1.96 USD Billion in the year 2024.
- Inactivated Vaccines is the Fastest growing segment in Global Travel Vaccine Market to 2032 with a Growth rate of 10.60 % in forecast period 2025-2032.
-
Global Travel Vaccine Market to 2032, By Composition
- Combination Vaccines is the largest segment in Global Travel Vaccine Market to 2032 with a revenue of 4.58 USD Billion in the year 2024.
- Combination Vaccines is the Fastest growing segment in Global Travel Vaccine Market to 2032 with a Growth rate of 9.88 % in forecast period 2025-2032.
Global Travel Vaccine Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Johnson & Johnson Services, Inc. | |||
| Pfizer Inc. | |||
| Sanofi | |||
| GSK plc. | |||
Global Travel Vaccine Market Geographical Sales Distribution, 2018-2032 USD Billion
Global Travel Vaccine Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Global Travel Vaccine Market is segmented based on Segmentation Route of Administration,Disease,Gender,Distribution Channel,Age Group,Patient Type,Category,Type,Composition.
Global Travel Vaccine Market was valued at USD 6.60(Revenue in USD Billion) in 2022.
Global Travel Vaccine Market is projected to grow at a CAGR of 9.76% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the Global Travel Vaccine Market, holding a largest market share of 5.42 USD Billion in 2024
Global Travel Vaccine Market Scope
Global Travel Vaccine Market Segmentation & Scope
Route of Administration
- Injectable
- Oral
Disease
- Others
- Polio
- COVID-19
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Gender
- Male
- Female
Distribution Channel
- B2C
- B2B
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Patient Type
- Geriatric
- Pediatric
- Adult
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Type
- Live-Attenuated Vaccines
- Inactivated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Toxoid Vaccines
- Viral Vector Vaccines
- DNA Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Frequently Asked Questions
The Global Travel Vaccine Market is segmented based on Segmentation Route of Administration,Disease,Gender,Distribution Channel,Age Group,Patient Type,Category,Type,Composition.
Global Travel Vaccine Market was valued at USD 6.60(Revenue in USD Billion) in 2022.
Global Travel Vaccine Market is projected to grow at a CAGR of 9.76% during the forecast period of 2024 to 2032.
The estimated market value of the Global Travel Vaccine Market for final year is USD 12.94 (USD Billion).
Global Travel Vaccine Market Company Profiling
Frequently Asked Questions
The Global Travel Vaccine Market is segmented based on Segmentation Route of Administration,Disease,Gender,Distribution Channel,Age Group,Patient Type,Category,Type,Composition.
Global Travel Vaccine Market was valued at USD 6.60(Revenue in USD Billion) in 2022.
Global Travel Vaccine Market is projected to grow at a CAGR of 9.76% during the forecast period of 2024 to 2032.
The estimated market value of the Global Travel Vaccine Market for final year is USD 12.94 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.